Cargando…
Yeast techniques for modeling drugs targeting Bcl-2 and caspase family members
Development of drugs targeting Bcl-2 relatives and caspases, for treating diseases including cancer and inflammatory disorders, often involves measuring interactions with recombinant target molecules, and/or monitoring cancer cell killing in vitro. Here, we present yeast-based methods for evaluating...
Autores principales: | Beaumont, T E, Shekhar, T M, Kaur, L, Pantaki-Eimany, D, Kvansakul, M, Hawkins, C J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674352/ https://www.ncbi.nlm.nih.gov/pubmed/23640461 http://dx.doi.org/10.1038/cddis.2013.143 |
Ejemplares similares
-
Caspase Inhibitors of the P35 Family Are More Active When Purified from Yeast than Bacteria
por: Brand, Ingo L., et al.
Publicado: (2012) -
Analysis of the minimal specificity of caspase-2 and identification of Ac-VDTTD-AFC as a caspase-2-selective peptide substrate
por: Kitevska, Tanja, et al.
Publicado: (2014) -
Functional and biochemical characterization of the baculovirus caspase inhibitor MaviP35
por: Brand, I L, et al.
Publicado: (2011) -
Structural biology of the Bcl-2 family and its mimicry by viral proteins
por: Kvansakul, M, et al.
Publicado: (2013) -
The Bcl-2 Family in Host-Virus Interactions
por: Kvansakul, Marc, et al.
Publicado: (2017)